Indo-US Vaccine Action Programme Joint Statement extended till 2027: The present five-year Indo-US Vaccine Action Programme (VAP) Joint Statement has been extended till 2027.
October 2022 Current Affairs Quiz
It is a unique bilateral programme. It is implementing by the Department of Biotechnology (DBT), India, and National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA since July 1987.
Aim: To improvise the current knowledge of vaccine science to strengthen the scientific basis for future vaccine design.